Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles.
Journal: bioRxiv : the preprint server for biology
Published: June 26, 2025
Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles.
Journal: NPJ vaccines
Published: June 07, 2025
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.
Journal: Journal of virology
Published: January 14, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature.
Journal: Cell reports
Published: December 10, 2019
Single-Cell RNA-Sequencing Identifies Activation of TP53 and STAT1 Pathways in Human T Lymphocyte Subpopulations in Response to Ex Vivo Radiation Exposure.
Journal: International journal of molecular sciences
Published: April 01, 2019
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.
Journal: Cell
Published: January 31, 2019
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
Journal: PloS one
Published: January 13, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026